Articles Tagged With: Sepsis
-
Mortality in Sepsis Patients Treated with Piperacillin-Tazobactam vs. Cefepime
A retrospective cohort study that included more than 7,000 patients with sepsis and no clear indication for anti-anaerobic coverage found receipt of piperacillin-tazobactam was associated with higher mortality and increased duration of organ dysfunction compared to cefepime.
-
Another Step in the Journey to Combat Diagnostic Errors in Hospitalized Patients
Diagnostic errors in hospitalized patients who died or were transferred to the intensive care unit were common in this large retrospective, multicenter trial and frequently associated with patient harm. Problems with clinical assessment and ordering and interpreting tests were the most prevalent diagnostic process faults, with sepsis the diagnosis most associated with diagnostic error.
-
ED Malpractice Claims Alleging Missed Sepsis Include These Allegations
Plaintiffs’ attorneys are increasingly scrutinizing ED care for failure to promptly identify and treat sepsis.
-
Lack of Data Is a Challenge for ED Sepsis AI Tools
When a patient first arrives at an ED, there usually is not much hard data available. This makes it very challenging for triage nurses to determine if sepsis is a possibility.
-
Does AI-Driven Tool Improve Evidence-Based Care and Reduce Sepsis Mortality?
New data show that an artificial intelligence-driven tool, deployed in UC San Diego Health emergency departments, can not only pick up on the subtle signs of sepsis at an early stage, but the data also strongly suggest that use of the tool can significantly reduce mortality.
-
Pediatric Sepsis Criteria Focus on Organ Dysfunction Indicators
The new criteria mark the first update to pediatric sepsis criteria in nearly two decades.
-
Does Alkaline Phosphatase Reduce Sepsis-Associated Acute Kidney Injury?
This Phase III, international, multicenter, double-blind, randomized controlled trial did not show a reduction in 28-day all-cause mortality with ilofotase alfa (recombinant human alkaline phosphatase). However, the study showed evidence to suggest that ilofotase alfa reduced major adverse kidney events at 90 days, mainly driven by lowering the incidence of renal replacement therapy through day 90 in these patients.
-
A Partial List of 2023 Lawsuits on Abortion and Reproductive Rights
Reproductive rights attorneys were busy in 2023 and are continuing the legal fight in 2024.
-
The IP Role in Sepsis
The Centers for Disease Control and Prevention has issued core elements for hospital sepsis programs, calling for a multidisciplinary team to prevent, detect, and treat these life-threatening systemic breakdowns.
-
New Sepsis Rule Puts Teeth Behind the SEP-1 Bundle, Putting Revenue at Risk for Providers Who Fail to Meet Benchmarks
A coalition of large healthcare associations, including the American College of Emergency Physicians, is taking issue with a new rule from the Center for Medicare & Medicaid Services that will require hospitals to meet the provisions outlined in the Severe Sepsis/Septic Shock Management Bundle, a series of labs, measurements, and therapies often referred to as SEP-1.